search
Back to results

Psychoeducative Treatment of FEP With Mobile Training

Primary Purpose

Psychosis, Psychological, Therapy

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Experimental group
Control group
Sponsored by
International University of La Rioja
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Psychosis focused on measuring first psychotic episode, mobile app intervention

Eligibility Criteria

14 Years - 19 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age of the patient between 14-19 years
  • The presence of at least 1 positive psychotic symptom (delusions or hallucinations) before age 19 years and 1 of the following diagnoses from DSM-5 (Apa., 2013): schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar disorder, major depressive disorder with psychotic features, brief psychotic disorder, or psychosis not otherwise specified.
  • Be at least two months without presenting acute psychotic symptoms (delusions or hallucination).
  • Written consent given by the patient, parents and / or legal representative.(n this case they must accept to participate both, minor and tutor, concretely, the minors since from the age of 14 also have to accept to participate. )
  • Access to a smartphone

Exclusion Criteria:

  • Abuse and dependence on toxicants (use is accepted).
  • Presence of organic diseases of the central nervous system, mental retardation or generalized developmental disorders

Sites / Locations

  • Ana Belén CalvoRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Experimental group

Control group

Arm Description

Mobile psychotherapy (5 modules) plus treatment as usual

Control group: Treatment as usual The description of this group, the control group, corresponds to the treatment to receive the usual treatment that is received on a regular basis, we will not perform any additional intervention

Outcomes

Primary Outcome Measures

Change from Baseline in psychotic symptoms
Assessment of psychotic symptoms are assessed using the Positive and Negative Syndrome Scale

Secondary Outcome Measures

Change from Baseline in affective symptoms
The mood was evaluated using the Hamilton Rating Scale for Depression
Change from Baseline in anxiety level
Anxiety is measured using the State-Trait Anxiety Inventory
Change From Baseline in functionality
The functionality is measure using Children's Global Assessment Scale
Change From Baseline in functionality II
The functionality is measure using Global Assessment of Functioning Scale
Change From Baseline in functionality III
The functionality is measure using Strauss Carpenter Rating Scale
Change from baseline in prognosis I
Number of relapses, hospitalizations and visits to the ER.
Change from baseline in drug´s use
The consumption is measured using the ASI (ASI-6 scale)

Full Information

First Posted
May 2, 2017
Last Updated
April 18, 2022
Sponsor
International University of La Rioja
search

1. Study Identification

Unique Protocol Identification Number
NCT03161249
Brief Title
Psychoeducative Treatment of FEP With Mobile Training
Official Title
Psychoeducative Treatment of First Episode Psychosis With Mobile Training:Study Protocol for a Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2020 (Actual)
Primary Completion Date
September 2022 (Anticipated)
Study Completion Date
December 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
International University of La Rioja

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of the study is to evaluate the effectiveness of an online intervention through a mobile application, specifically designed for adolescents with a First Psychotic Episode (FEP), as a complement to the pharmacological and therapeutic interventions they receive at their referral center (Treatment as usual). To do this, a longitudinal study will be carried out on patients with FEP and between the ages of 14 and 19, who come to the Child and Adolescent Psychiatry Service of the General Universitarian Hospital "Gregorio Marañón" in Madrid. Adolescents will be randomly assigned to an experimental group, where they will receive standard treatment plus online intervention, or a control group, where they will receive standard treatment. This online intervention, the continuation of the work of this same team researcher in the "PIENSA program", aims to address little of the more traditional treatments and treatments such as community functioning, quality of life or affective symptoms. In addition, it will increase disease awareness, which will lead to greater adherence to treatment and fewer relapses and rehospitalizations.
Detailed Description
Clinical assessment criteria Data on the major clinical and demographic variables are entered in a data collection form. All patients are assessed at baseline and have been or will be assessed at 3 months after inclusion in the study. All the instruments used in the study have demonstrated appropriate psychometric properties, and were used in many studies Demographic data Data are collected on age, sex, level of education, living arrangements and employment or educational status. Assessment of psychotic symptoms are assessed using the Positive and Negative Syndrome Scale. The scale for the assessment of positive symptoms and negative symptoms. Trait and state anxiety will be measured using the State-Trait Anxiety Inventory. The mood is evaluated using the Hamilton Rating Scale for Depression. We measure patient insight into their illness using the Scale to Assess Unawareness of Mental Disorders. We use the Strauss and Carpenter Prognostic Scale. We also assess the overall function of patients using a Spanish version of the Global Assessment of Functioning Scale. The level of functioning was measured using the Children's Global Assessment Scale. We measure this variable using the "Morisky" Medication Adherence Scale. We measure patient functional status using the Functioning Assessment Short Test. The consumption is measured using the ASI (Addition severity index) scale. The quality of life is measured using the World Health Organization Quality of Life WHOQOL-BREF Questionnaire .In addition, we assess quality of life using the EuroQoL questionnaire. Mobile Application Android Mobile app with a web support and administration application, along with a cloud based backend database, which will register fine-grain interactions between the users and the app, in order to make possible the generation of relevant granular data and key performance indicators to support a wide range of further analysis. This application will be designed and developed using Software Engineering-based Agile Methodologies, under SCRUM principles (empiric control of the development process, using continuous feedback processes). The whole mobile app functionality and its user interfaces and interactions will be designed under the premises of maximizing the User experience, as a factor contributing to the adherence of users to the treatment. On the security side, all of the communications between the mobile app and the supporting backend will be protected by means of a "SSL" digital certificate on the server, providing end to end encrypted communications Data Management For security, all data introduce in database will have an internal code, and will be checked by another data manager, in order to guarantee the data security. Intervention programme Mobile phone App treatment The psychoeducational app programme is composed of 5 modules: Psychoeducative Module (12 sessions) Module of recognition of symptomatology and prevention of relapses Module Troubleshooting Mindfulness Module Module of social skills

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychosis, Psychological, Therapy
Keywords
first psychotic episode, mobile app intervention

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is an experimental, randomized and longitudinal study of repeated measures with independent groups (Treatment group or experimental group: EG and control group: CG) which includes pre and post treatment. This randomized clinical trial includes blind evaluators.
Masking
Investigator
Masking Description
blind evaluators
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental group
Arm Type
Experimental
Arm Description
Mobile psychotherapy (5 modules) plus treatment as usual
Arm Title
Control group
Arm Type
Other
Arm Description
Control group: Treatment as usual The description of this group, the control group, corresponds to the treatment to receive the usual treatment that is received on a regular basis, we will not perform any additional intervention
Intervention Type
Behavioral
Intervention Name(s)
Experimental group
Other Intervention Name(s)
Psychotherapy group (5 modules)
Intervention Description
The experimental group receiving mobile treatment: treatment as usual plus a psychotherapy intervention by the telephone app (a total of 5 modules of psychotherapy: psychoeducation plus mindfulness plus alerts plus social wall plus problems solving)
Intervention Type
Other
Intervention Name(s)
Control group
Other Intervention Name(s)
Control group, or treatment as usual group
Intervention Description
Group that does not receive any treatment added to its usual treatment
Primary Outcome Measure Information:
Title
Change from Baseline in psychotic symptoms
Description
Assessment of psychotic symptoms are assessed using the Positive and Negative Syndrome Scale
Time Frame
Change from Baseline psychotic symptoms at 3 months
Secondary Outcome Measure Information:
Title
Change from Baseline in affective symptoms
Description
The mood was evaluated using the Hamilton Rating Scale for Depression
Time Frame
Change from baseline affective symptoms at 3 months
Title
Change from Baseline in anxiety level
Description
Anxiety is measured using the State-Trait Anxiety Inventory
Time Frame
Change from baseline anxiety symptoms at 3 months
Title
Change From Baseline in functionality
Description
The functionality is measure using Children's Global Assessment Scale
Time Frame
Change from Baseline functionality at 3 months
Title
Change From Baseline in functionality II
Description
The functionality is measure using Global Assessment of Functioning Scale
Time Frame
Change from baseline functionality at 3 months
Title
Change From Baseline in functionality III
Description
The functionality is measure using Strauss Carpenter Rating Scale
Time Frame
Change from baseline functionality at 3 months
Title
Change from baseline in prognosis I
Description
Number of relapses, hospitalizations and visits to the ER.
Time Frame
Change from baseline prognosis at 3 months
Title
Change from baseline in drug´s use
Description
The consumption is measured using the ASI (ASI-6 scale)
Time Frame
Change from baseline drug´s use at 3 months
Other Pre-specified Outcome Measures:
Title
Change from baseline in adherence
Description
The adherence is measured using Morisky Medication Adherence Scale
Time Frame
Change from baseline adherence level at 3 months
Title
Change from baseline in quality of life
Description
The quality of life is measured using the World Health Organization Quality of Life WHOQOL
Time Frame
Change from baseline quality of life at 3 months
Title
Change from baseline in quality of life II
Description
The quality of life is measured using EuroQoL scale
Time Frame
Change from baseline quality of life at 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age of the patient between 14-19 years The presence of at least 1 positive psychotic symptom (delusions or hallucinations) before age 19 years and 1 of the following diagnoses from DSM-5 (Apa., 2013): schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar disorder, major depressive disorder with psychotic features, brief psychotic disorder, or psychosis not otherwise specified. Be at least two months without presenting acute psychotic symptoms (delusions or hallucination). Written consent given by the patient, parents and / or legal representative.(n this case they must accept to participate both, minor and tutor, concretely, the minors since from the age of 14 also have to accept to participate. ) Access to a smartphone Exclusion Criteria: Abuse and dependence on toxicants (use is accepted). Presence of organic diseases of the central nervous system, mental retardation or generalized developmental disorders
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ana Calvo, PI
Phone
941210211
Email
anabelen.calvo@unir.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ana Calvo, PI
Organizational Affiliation
UNIR
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ana Belén Calvo
City
Madrid
Country
Spain
Individual Site Status
Recruiting

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30804818
Citation
Barbeito S, Sanchez-Gutierrez T, Mayoral M, Moreno M, Rios-Aguilar S, Arango C, Calvo A. Mobile App-Based Intervention for Adolescents With First-Episode Psychosis: Study Protocol for a Pilot Randomized Controlled Trial. Front Psychiatry. 2019 Feb 5;10:27. doi: 10.3389/fpsyt.2019.00027. eCollection 2019.
Results Reference
derived

Learn more about this trial

Psychoeducative Treatment of FEP With Mobile Training

We'll reach out to this number within 24 hrs